The Effect of the COVID-19 Pandemic on Pituitary Surgeries
Copyright © 2024. Published by Elsevier Inc..
PURPOSE: As the COVID-19 pandemic spread to the United States in 2020, there was an impetus towards postponing or ceasing non-urgent transsphenoidal pituitary surgeries to prevent spread of the virus. Some centers encouraged transcranial approaches for patients with declining neurologic function. However, no large-scale data exists evaluating the effects this had on national pituitary practice patterns.
METHODS: Pituitary surgeries in the National Inpatient Sample were identified from 2017-2020. Surgeries in 2020 were compared to the three years prior to determine any differences in demographics, surgical trends/approaches and perioperative outcomes. In 2020, there was a decline in overall pituitary surgeries (34.2 vs. 36.3%, odds ratio (OR) 0.88, p<0.001) yet transsphenoidal approaches represented a higher proportion of interventions (69.0 vs. 64.9%, p<0.001). Neurosurgical complications were higher (51.9 vs. 47.4%, OR 1.13, p<0.001) and patients were less likely to be discharged home (86.4 vs. 88.5%, OR 0.84, p<0.001). This was especially true in April 2020 during the first peak in COVID-19 cases when transcranial approaches and odds of mortality/complications were highest.
CONCLUSIONS: In 2020, transsphenoidal surgery remained the preferred approach for pituitary tumor resection despite initial recommendations against the approach to prevent COVID-19 spread. Pituitary surgeries had a higher risk of periprocedural complications despite accounting for preoperative comorbidities, COVID-19 infection status, and surgical approach, suggesting that an overwhelmed hospital system can negatively influence surgical outcomes in non-infected patients.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
World neurosurgery - (2024) vom: 05. Apr. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Luther, Evan [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Revised 07.04.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1016/j.wneu.2024.03.156 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM370729811 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM370729811 | ||
003 | DE-627 | ||
005 | 20240408233324.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240408s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.wneu.2024.03.156 |2 doi | |
028 | 5 | 2 | |a pubmed24n1369.xml |
035 | |a (DE-627)NLM370729811 | ||
035 | |a (NLM)38583567 | ||
035 | |a (PII)S1878-8750(24)00542-4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Luther, Evan |e verfasserin |4 aut | |
245 | 1 | 4 | |a The Effect of the COVID-19 Pandemic on Pituitary Surgeries |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 07.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a Copyright © 2024. Published by Elsevier Inc. | ||
520 | |a PURPOSE: As the COVID-19 pandemic spread to the United States in 2020, there was an impetus towards postponing or ceasing non-urgent transsphenoidal pituitary surgeries to prevent spread of the virus. Some centers encouraged transcranial approaches for patients with declining neurologic function. However, no large-scale data exists evaluating the effects this had on national pituitary practice patterns | ||
520 | |a METHODS: Pituitary surgeries in the National Inpatient Sample were identified from 2017-2020. Surgeries in 2020 were compared to the three years prior to determine any differences in demographics, surgical trends/approaches and perioperative outcomes. In 2020, there was a decline in overall pituitary surgeries (34.2 vs. 36.3%, odds ratio (OR) 0.88, p<0.001) yet transsphenoidal approaches represented a higher proportion of interventions (69.0 vs. 64.9%, p<0.001). Neurosurgical complications were higher (51.9 vs. 47.4%, OR 1.13, p<0.001) and patients were less likely to be discharged home (86.4 vs. 88.5%, OR 0.84, p<0.001). This was especially true in April 2020 during the first peak in COVID-19 cases when transcranial approaches and odds of mortality/complications were highest | ||
520 | |a CONCLUSIONS: In 2020, transsphenoidal surgery remained the preferred approach for pituitary tumor resection despite initial recommendations against the approach to prevent COVID-19 spread. Pituitary surgeries had a higher risk of periprocedural complications despite accounting for preoperative comorbidities, COVID-19 infection status, and surgical approach, suggesting that an overwhelmed hospital system can negatively influence surgical outcomes in non-infected patients | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a pandemic | |
650 | 4 | |a pituitary tumor | |
650 | 4 | |a surgical outcomes | |
650 | 4 | |a transcranial | |
650 | 4 | |a transsphenoidal | |
700 | 1 | |a Ramsay, Ian |e verfasserin |4 aut | |
700 | 1 | |a Govindarajan, Vaidya |e verfasserin |4 aut | |
700 | 1 | |a Berke, Chandler N |e verfasserin |4 aut | |
700 | 1 | |a Makhoul, Vivien |e verfasserin |4 aut | |
700 | 1 | |a Merenzon, Martin |e verfasserin |4 aut | |
700 | 1 | |a Berry, Katherine |e verfasserin |4 aut | |
700 | 1 | |a Morell, Alexis |e verfasserin |4 aut | |
700 | 1 | |a Eichberg, Daniel |e verfasserin |4 aut | |
700 | 1 | |a Lu, Victor |e verfasserin |4 aut | |
700 | 1 | |a Shah, Ashish |e verfasserin |4 aut | |
700 | 1 | |a Komotar, Ricardo J |e verfasserin |4 aut | |
700 | 1 | |a Ivan, Michael E |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t World neurosurgery |d 2010 |g (2024) vom: 05. Apr. |w (DE-627)NLM197924441 |x 1878-8769 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:05 |g month:04 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.wneu.2024.03.156 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 05 |c 04 |